Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits

Chemotherapy

Volumn 47, Issue 2, 2001, Pages 128-135

  Najjar, Tawfeeg A O ^a   Saad, Sherif Y ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Albumin; Blood urea nitrogen; Cisplatin; Creatinine; Nephrotoxicity; Pharmacokinetics; Rabbits

Indexed keywords

ALBUMIN; CISPLATIN; CITRIC ACID; CREATININE; PLATINUM; STREPTOZOCIN; UREA;

ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; COMPARTMENT MODEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELIMINATION; DRUG HALF LIFE; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; STREPTOZOCIN DIABETES;

ANIMALS; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; CISPLATIN; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; KIDNEY DISEASES; MALE; RABBITS; UREA;

EID: 0035121463     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048512     Document Type: Article

References (33)

1. Changes of lipid peroxide levels in rat tissues after cisplatin administration
2. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues
3. Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats
4. Renal metallothionein and platinum levels in diabetic and nondiabetic rats injected with cisplatin
5. Renal accumulation and urinary excretion of cisplatin in diabetic rats
6. Influence of streptozotocin (STZ)-induced diabetes, dextrose diuresis and acetone on cisplatin nephrotoxicity in Fisher 344 (F344) rats
7. Attenuation of cisplatin nephrotoxicity by streptozotocin-induced diabetes
8. Improvement of cis-dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model
9. Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity
10. Studies on adequate intervals of cisplatin administration to ameliorate cisplatin-induced nephrotoxicity
11. Pharmacokinetic changes of methotrexate after intravenous administration to streptozotocin-induced diabetes mellitus rats
12. Pharmacokinetics of a new proton-pump inhibitor, YJA-20379-8, after intravenous and oral administration to rats with streptozotocin-induced diabetes mellitus
13. On the colorimetric determination of creatinine by the Jaffe reaction
14. Reduced nicotinamide adenine dinucleotide-coupled reaction for emergency blood urea estimation
15. The quantitation of albumin based on dye linear binding capacity
16. Inactivation of cis-diamminedichloroplatinum (II) in blood and protection of its toxicity by sodium thiosulphate in rabbits
17. Clinical kinetics of intact cisplatin and some species
18. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammine-platinum(II) in man
19. Pharmacokinetics of platinum compounds
20. 14C]ethylenediamine dichloride in rat
21. Synthesis and distribution of a radiolabeled antitumor agent: Cis-diamminedichloroplatinum (II)
22. Coordination complexes of platinum as antitumor agents
23. Clinical studies of platinum coordination compounds in the treatment of various malignant diseases
24. The indices of systemic and regional hemodynamics in waking rats with streptozotocin diabetes
25. Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats
26. Inhibition of renal ornithine decarboxylase activity fails to reduce kidney size and urinary albumin excretion in diabetic rats with manifest kidney hypertrophy
27. Renal hypertrophy in experimental diabetes. A morphometric study
28. Reduced renal responses to volume expansion in streptozotocin-induced diabetic rats
29. Reduced renal sympathoinhibition in response to acute volume expansion in diabetic rats
30. Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration
31. Effect of insulin on plasma renin activity, plasma atrial natriuretic peptide and body fluid volume in diabetes mellitus
32. Effects of cisplatin on urinary thromboxane B2 excretion
33. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus